Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Invertebrate gamma-aminobutyric acid receptors (iGABARs) are essential components of the invertebrate central nervous system, serving as the primary mediators of inhibitory neurotransmission (Buckingham, S. D., et al., 2005, 'Invertebrate GABA receptors', Progress in Neurobiology). These receptors are members of the Cys-loop superfamily of ligand-gated ion channels and function as pentameric chloride-selective pores that hyperpolarize neurons upon activation by the neurotransmitter GABA (Sattelle, D. B., et al., 1991, 'GABA receptors of insects', Advances in Insect Physiology). They are of significant pharmacological importance as they are the primary targets for several major classes of insecticides and ectoparasiticides, including phenylpyrazoles like fipronil and the newer isoxazoline class such as fluralaner (Casida, J. E., 2015, 'Golden age of insecticide research and development', Annual Review of Entomology). These compounds typically act as non-competitive antagonists that bind within the channel pore, blocking chloride conductance and causing lethal hyperexcitation of the insect nervous system (Bloomquist, J. R., 2003, 'Chloride channels as tools for developing selective insecticides', Archives of Insect Biochemistry and Physiology). A key feature of these targets is the structural divergence from mammalian GABA-A receptors, which allows for high selective toxicity toward pests and parasites while maintaining safety for vertebrate hosts (Zhao, X., et al., 2003, 'Fipronil: action at the GABA receptor', Pest Management Science). Resistance to these drugs often arises through mutations in the RDL (Resistance to dieldrin) gene, which encodes the principal GABA receptor subunit in many insect species (Ffrench-Constant, R. H., et al., 2000, 'Cyclodiene insecticide resistance: from molecular to population genetics', Annual Review of Entomology). Understanding the molecular pharmacology of iGABARs remains critical for the development of sustainable pest management strategies and novel antiparasitic therapies.
Non-competitive antagonism of the GABA-gated chloride channel, leading to the blockage of inhibitory signals and subsequent over-excitation of the nervous system.
9 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Invertebrate gamma-aminobutyric acid receptor (iGABAR) (iGABAR).